Zobrazeno 1 - 10
of 64
pro vyhledávání: '"35"'
Autor:
Marianna Beggio, D. Astorri, Leonardo Punzi, A. Ghiraldello, Andrea Doria, L. Friso, Bernd Raffeiner, L. Bernardi, Roberto Padoan, Costantino Botsios, Francesca Ometto
Publikováno v:
Annals of the Rheumatic Diseases. 75:494.1-494
Objectives To investigate etanercept (ETN) serum levels and anti-etanercept antibodies (AEA) and evaluate whether ETN levels are associated with SDAI remission in rheumatoid arthritis patients in DAS28 remission treated with full-dose (25 mg twice we
Publikováno v:
Annals of the Rheumatic Diseases. 74:694.2-695
Background Pneumocystis pneumonia (PCP) is an opportunistic infectious disease which sometimes occurs during immunosuppressive therapy against systemic autoimmune diseases (SIDs), including rheumatoid arthritis (RA). PCP in SIDs patients manifests as
Publikováno v:
Annals of the Rheumatic Diseases. 71:647.12-647
Background Iguratimod (T-614) is a novel and small molecule DMARD discovered by Toyama Chemical Co., Ltd. It was characterized by inhibitory effects on immunoglobulin production in B cells without suppression of proliferative response. Iguratimod als
Autor:
Ca Scirè, Piercarlo Sarzi-Puttini, M. Astegiano, Richard Borrelli, M. Antivalle, Greta Carrara, D. G. Ribaldone, M. C. Ditto, Silvana Parisi, G. Landolfi, Gian Paolo Caviglia, Enrico Fusaro, A. Zanetti
Publikováno v:
Annals of the Rheumatic Diseases. 80:335.1-335
Background:the close relationship between joints and gut inflammation has long been known and several data suggest that the dysbiosis could represents the link between Spondyloarthritis (SpA) and Inflammatory Bowel Diseases (IBD). To date, the manipu
Publikováno v:
Annals of the Rheumatic Diseases. 80:1136.1-1136
Background:Abatacept, a selective inhibitor of T cell co-stimulation, is often used as a second-line biologic disease-modifying anti-rheumatic drug (bDMARD) after the failure of tumour necrosis factor inhibitor (TNFi) in Rheumatoid Arthritis (RA). Ho
Autor:
G.-R. Burmester, B. Muche, H. C. Brandt, M. Verba, S. Lüders, Denis Poddubnyy, H. Käding, J. Brandt-Juergens, Murat Torgutalp, Hildrun Haibel, K. Karberg, Fabian Proft, Mikhail Protopopov, V. Rios Rodriguez, S. Zinke, J. Schally
Publikováno v:
Annals of the Rheumatic Diseases. 80:456.2-457
Background:Therapeutic decisions in RA patients should be based on regular disease activity assessment using scores like the Simplified Disease Activity Index (SDAI) or the Clinical Disease Activity Index (CDAI) [1]. The CDAI has the benefit of being
Autor:
J. Ivorra Cortés, C. Riesco Barcena, I. Martínez Cordellat, S. Leal Rodriguez, C. Pávez Perales, A. V. Huaylla Quispe, F.M. Ortiz Sanjuan, C. Alcañiz Escandell, I Cánovas Olmos, E. Grau Garcia, I. Chalmeta Verdejo, E. Vicens Bernabeu, R. Negueroles Albuixech, L. González Puig, M. De la Rubia Navarro, JJ Fragio Gil, JE Oller Rodriguez, C. Nájera Herranz, JA Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 80:964.2-965
Background:Polymyalgia Rheumatica (PMR) is a common inflammatory disease found in elderly patients and results in a high burden of long-term CS-based therapies. Most patients diagnosed with PMR have a good evolution following the introduction of medi
Autor:
Tore K Kvien, David J. Warren, Silje W Syversen, G. L. Goll, Nils Bolstad, Liz Loli, J. E. Gehin, E. Lie, Trine Bjøro, Joseph O. Sexton, A. Wierød
Publikováno v:
Annals of the Rheumatic Diseases. 79:868-869
Background:Lack or loss of response to TNFα-inhibitors can be caused by subtherapeutic drug levels and anti-drug antibodies (ADAb). Knowledge about associations between clinical efficacy and drug levels as well as occurrence of ADAb is limited in pa
Publikováno v:
Thorax
Background Severe exacerbations of COPD are commonly associated with hyperglycaemia, which predicts adverse outcomes. Metformin is a well-established anti-hyperglycaemic agent in diabetes mellitus, possibly augmented with anti-inflammatory effects, b
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 87:295-301
Objective The pathogenesis of Parkinson9s disease (PD) involves complex interactions between environmental and genetic factors. Metabolomics can shed light on alterations in metabolic pathways in many diseases, including neurodegenerative diseases. I